Skip to content

Goal-directed CPR Using Cerebral Oximetry

Goal-Directed Cardiopulmonary Resuscitation in Cardiac Arrest Using a Novel Physiological Target

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04924985
Enrollment
106
Registered
2021-06-14
Start date
2022-02-11
Completion date
2025-02-14
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemia, Reperfusion Injury

Keywords

CPR

Brief summary

The proposed study is a single-center, randomized controlled pilot trial of adults who suffer in-hospital cardiac arrests. Using cerebral oxygenation and end-tidal carbon dioxide physiological targets to predict survival and neurological outcome, the impact of physiological-feedback CPR will be assessed. 150 adult patients who have a cardiac arrest event at NYU Tisch Hospital will be randomized to one of two treatment groups: (1) Physiological-Feedback CPR or (2) Non-Physiological (Audiovisual) Feedback CPR.

Interventions

OTHERNon-Physiological Feedback CPR

Non-physiologically guided CPR using AV feedback (integrated into defibrillators)

OTHERPhysiological Feedback CPR

Physiological feedback CPR using an optimal regional O2 Saturation (rSO2), End-tidal CO2 (ETCO2) or combined (rSO2/ETCO2) target

Sponsors

NYU Langone Health
Lead SponsorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. In-hospital cardiac arrest patient 2. Age ≥18 years 3. Age \<80 years 4. CPR lasting ≥5 minutes

Exclusion criteria

1. Patients \< 18 years of age or \> 80 years of age 2. Out of hospital cardiac arrest patients 3. ≥3 acute organ failures (defined as acute renal failure requiring dialysis, fulminant liver failure i.e. liver failure with INR≥1.5, respiratory failure requiring mechanical ventilation) 4. Repeat in-hospital cardiac arrest event within 14 days of a prior cardiac arrest 5. Presence of known raised intracranial pressure 6. Presence of known traumatic brain injury or subarachnoid hemorrhage \<14 days old, frontal lobe brain tumors or subdural hemorrhage 7. Hyperbilirubinemia \>1.0 mg/dl (based on the absorption of near-infrared light by bilirubin) 8. Resuscitation using extra-corporeal membrane oxygenation (ECMO)

Design outcomes

Primary

MeasureTime frame
Rate of Return of Spontaneous Circulation (ROSC)Day 0

Secondary

MeasureTime frameDescription
Cerebral Performance Category (CPC) ScoreDay 1-2Total range of score is 1 (Good cerebral performance) to 5 (Brain death). The higher the score, the worse the clinical condition.
Change in mean rSO2 during CPR as markers of the quality of resuscitationDay 0
Change in mean ETCO2 during CPR as markers of the quality of resuscitationDay 0
Release of interleukin (IL)-6Day 0
Release of LactateDay 0

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSam Parnia, MD, PhD

NYU Langone Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026